Wynn Macau (WYNMF) Stock Chart & Stock Price History → The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way (From Smallcaps Daily) (Ad) Free WYNMF Stock Alerts $1.00 0.00 (0.00%) (As of 05/7/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisAnalyst ForecastsChartFinancialsHeadlinesSEC FilingsShort Interest Wynn Macau Stock Price Performance5 Day Performance+0.04%1 Month Performance-0.10%3 Month Performance+16.84%6 Month Performance+13.52%Year-To-Date Performance+27.13%1 Year Performance-0.10% Receive WYNMF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Wynn Macau and its competitors with MarketBeat's FREE daily newsletter Email Address Ad InvestorPlaceThe new financial threat that could wipe out millions…During the Internet boom, companies like Pets.com were supposed to be promising investments riding the wave of a new tech boom. But then they were gone within a blink of an eye. One of the most successful investors in history just stepped forward to say the same thing is about to happen to AI stocks.Pay close attention to this important video WYNMF Stock Chart for Wednesday, May, 8, 2024 WYNMF Chart by TradingView Wynn Macau Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/06/2024$1.00$1.00+0.04%$1.00$1.0010,014 shs$5.23 billion05/03/2024$0.93$1.00+7.38%$1.00$1.00300 shs$5.23 billion05/02/2024$0.92$0.93+0.82%$0.93$0.935,000 shs$4.87 billion05/01/2024$0.92$0.92$0.92$0.92100 shs$4.83 billion04/25/2024$0.92$0.92$0.92$0.92100 shs$4.83 billion04/24/2024$0.91$0.92+1.24%$0.92$0.92100 shs$4.83 billion Get the Latest News and Ratings for WYNMF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Wynn Macau and its competitors with MarketBeat's FREE daily newsletter. 04/17/2024$0.91$0.91$0.91$0.91150 shs$4.77 billion04/16/2024$0.95$0.91-4.09%$0.91$0.91150 shs$4.77 billion04/15/2024$0.95$0.95$0.95$0.951,000 shs$4.97 billion04/12/2024$0.99$0.95-4.24%$0.95$0.951,000 shs$4.97 billion04/11/2024$0.99$0.99-0.01%$0.99$0.985,400 shs$5.19 billion04/10/2024$1.00$0.99-0.79%$0.99$0.985,400 shs$5.19 billion04/09/2024$1.00$1.00$1.00$0.9716,085 shs$5.24 billion04/08/2024$0.94$1.00+6.38%$1.00$0.9716,085 shs$5.24 billion04/05/2024$0.94$0.94$0.96$0.94177,500 shs$4.92 billion04/04/2024$0.94$0.94$0.94$0.94177,500 shs$4.92 billion04/03/2024$0.90$0.94+4.44%$0.94$0.941,000 shs$4.92 billion04/02/2024$0.90$0.90$0.90$0.901,000 shs$4.71 billion04/01/2024$0.86$0.90+5.14%$0.90$0.901,000 shs$4.71 billion03/29/2024$0.86$0.86-0.75%$0.88$0.866,916 shs$4.48 billion03/28/2024$0.86$0.86$0.88$0.8640,000 shs$4.52 billion03/27/2024$0.86$0.86$0.86$0.8640,000 shs$4.52 billion03/26/2024$0.87$0.86-0.35%$0.86$0.8640,000 shs$4.52 billion03/22/2024$0.87$0.87$0.87$0.874,000 shs$4.53 billion03/21/2024$0.83$0.87+3.71%$0.87$0.874,000 shs$4.53 billion03/20/2024$0.83$0.83$0.83$0.839 shs$4.37 billion03/19/2024$0.83$0.83$0.83$0.833,600 shs$4.37 billion03/15/2024$0.87$0.83-3.83%$0.86$0.833,500 shs$4.37 billion03/14/2024$0.79$0.87+9.48%$0.87$0.85200 shs$4.54 billion03/12/2024$0.79$0.79-0.33%$0.79$0.79200 shs$4.14 billion03/11/2024$0.77$0.79+2.69%$0.79$0.79200 shs$4.15 billion03/06/2024$0.77$0.77$0.77$0.772,998 shs$4.04 billion03/05/2024$0.78$0.77-0.99%$0.77$0.772,998 shs$4.04 billion03/04/2024$0.81$0.78-3.37%$0.80$0.786,000 shs$4.08 billion03/01/2024$0.88$0.81-8.01%$0.81$0.8120,000 shs$4.22 billion02/29/2024$0.86$0.88+1.97%$0.88$0.88863 shs$4.59 billion02/28/2024$0.85$0.86+1.12%$0.86$0.861,000 shs$4.50 billion02/27/2024$0.85$0.85+0.06%$0.85$0.85200 shs$4.45 billion02/26/2024$0.88$0.85-3.44%$0.85$0.85100 shs$4.45 billion02/23/2024$0.88$0.880.00%$0.88$0.88500 shs$4.61 billionFidelity, Bezos, Goldman Bet Big on Tiny Biotech (Ad)Are you ready for a major shift in the investment world? There's a new drug The Wall Street Journal is calling the "King Kong" of drugs.Don't miss out on the "next Ozempic" >>>02/22/2024$0.85$0.88+3.49%$0.88$0.88500 shs$4.61 billion02/21/2024$0.93$0.85-9.00%$0.85$0.85500 shs$4.45 billion02/20/2024$0.90$0.93+3.86%$0.93$0.93510 shs$4.89 billion02/15/2024$0.90$0.90$0.90$0.902,000 shs$4.71 billion02/14/2024$0.85$0.90+6.02%$0.90$0.902,000 shs$4.71 billion02/13/2024$0.85$0.85$0.85$0.85695 shs$4.44 billion02/12/2024$0.90$0.85-5.68%$0.85$0.85695 shs$4.44 billion02/09/2024$0.86$0.90+5.26%$0.90$0.901,610 shs$4.71 billion02/08/2024$0.81$0.86+6.21%$0.86$0.857,400 shs$4.48 billion Related Companies: Hilton Grand Vacations Stock Price Chart V.F. Stock Price Chart Columbia Sportswear Stock Price Chart iQIYI Stock Price Chart Boyd Gaming Stock Price Chart Whirlpool Stock Price Chart Madison Square Garden Sports Stock Price Chart Planet Fitness Stock Price Chart Nexstar Media Group Stock Price Chart Academy Sports and Outdoors Stock Price Chart Receive WYNMF Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Wynn Macau and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:WYNMF) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyElon Musk Secret Crypto Plot ExposedCrypto 101 MediaAI “wealth window” is closing June 25thParadigm PressShocking: One AI startup's revenue could surge 4,735%Manward Press[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingCharles Payne Demystifies OptionsUnstoppable ProsperityWatch this FREE trading tutorial while it’s still availableInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Wynn Macau, Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
